| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 03/11/2008 | US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/11/2008 | CA2444561C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 03/11/2008 | CA2382489C Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 03/06/2008 | WO2008027854A2 Pharmaceutical compositions comprising hgh for oral delivery |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008025069A1 Methods of modulating cellular activity and compositions therefor |
| 03/06/2008 | WO2007131736A3 Use of 4, 17 beta-dihydroxyandrost-4-ene-3-one for treating cancers |
| 03/06/2008 | US20080058505 Modified parathyroid hormone/peptides for use in prevention and treatment of bone disorders |
| 03/06/2008 | US20080058383 Such as 2-methyl-2-(4-nitro-3-trifluoromethyl-phenylamino)-propan-1-ol; prostate cancer; cardiovascular disorders; psychological disorders |
| 03/06/2008 | US20080058361 Tetrahydrobenzfluorene derivatives |
| 03/06/2008 | US20080058259 Improve metabolism of humans; administering mixture of insulin-like growth factor and growth hormone; particlar pediatic humans |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057140 Use of a Lignan for the Manufacture of a Composition for Preventing or Alleviating of Symptoms Relating to Estrogen Deficiency |
| 03/06/2008 | US20080057076 Novel fibroblast growth factors |
| 03/06/2008 | CA2661521A1 Pharmaceutical compositions comprising hgh for oral delivery |
| 03/05/2008 | EP1894911A1 Vitamin d-like compound |
| 03/05/2008 | EP1893630A1 Steroids having a mixed androgenic and progestagenic profile |
| 03/05/2008 | EP1893182A2 Oral dosage forms comprising progesterone and methods of making and using the same |
| 03/05/2008 | EP0989993B1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 03/05/2008 | CN101137655A Androgen receptor modulator compounds and methods |
| 03/05/2008 | CN101137390A Novel angiogensis inhibitor |
| 03/04/2008 | US7338770 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 02/29/2008 | CA2558110A1 Composition and method for enhancing or promoting the activity of insulin, enhancing skeletal muscle growth, reducing skeletal muscle loss, and increasing the energy supply to skeletal muscle |
| 02/28/2008 | WO2008024433A2 Haloalkyl-substituted pyrimidinone derivatives |
| 02/28/2008 | WO2008023050A1 Acylated exendin-4 compounds |
| 02/28/2008 | WO2007144668A3 Process for the preparation of s-fluoromethyl-6, 9 -difluoro-11 -hydroxy-16 -methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates |
| 02/28/2008 | WO2007103282A3 Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
| 02/28/2008 | US20080051394 6H-Oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080050434 Novel Composition for Topical Delivery |
| 02/28/2008 | US20080050417 Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof |
| 02/28/2008 | US20080050381 Antihuman Baff Antibody |
| 02/28/2008 | US20080050315 Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1) |
| 02/28/2008 | US20080050314 Diagnostics and Therapeutics for Diseases Associated With Glycogen Synthase Kinase 3 Beta (Gsk3b) |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1892241A1 Novel piperidine derivative |
| 02/27/2008 | EP1891038A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators |
| 02/27/2008 | EP1890768A2 Novel phosphinic acid-containing thyromimetics |
| 02/27/2008 | EP1483266B1 Spiro compounds with npy antagonistic activity |
| 02/27/2008 | EP1453827B1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
| 02/27/2008 | EP1406649B1 Use of substances with oxytocin activity against climacteric disorders |
| 02/27/2008 | CN101132766A Tablet containing steroid hormones |
| 02/27/2008 | CN101130567A Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 02/27/2008 | CN101130025A Pill for warming Yang and benefiting Yin |
| 02/27/2008 | CN101129979A Orally taken traditional Chinese medicine composition for treating hyperthyroidism |
| 02/27/2008 | CN101129966A Traditional Chinese medicine for treating thyroid hyperfunction companioned with diarrhea |
| 02/27/2008 | CN101129784A Traditional Chinese medicine composition for treating endocrine dyscrasia |
| 02/27/2008 | CN101129744A Traditional Chinese medicine agentia for conditioning endocrine and method of preparing the same |
| 02/27/2008 | CN101129327A Micro-projection array having a beneficial agent containing coating |
| 02/27/2008 | CN101129310A Anti-dandruff shampoo of common camellia seed |
| 02/27/2008 | CN100371018C Calcitonin composition |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/27/2008 | CN100370967C Implantable gel compositions and preparing method of thereof |
| 02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 02/26/2008 | US7335655 Treating asthma with e.g. 2-(3-methoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]acetamide; potent, yet selective modulators of adenosine receptors |
| 02/26/2008 | US7335646 Compositions and methods for regulated protein expression in gut |
| 02/21/2008 | WO2008021338A2 Tricyclic oxazolidone derivatives useful as pr modulators |
| 02/21/2008 | WO2008021337A1 Oxazinan-2-one derivatives useful as pr modulators |
| 02/21/2008 | WO2008021309A1 Imidazolidin-2-one derivatives useful as pr modulators |
| 02/21/2008 | WO2007128088A3 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases |
| 02/21/2008 | WO2007122419A3 Therapeutic method for glycaemic control |
| 02/21/2008 | US20080045579 Oxazolidine derivatives as PR modulators |
| 02/21/2008 | US20080045567 Therapeutic Agent for Hyperlipemia and Therapeutic Agent for Diabetes |
| 02/21/2008 | US20080045560 Pyrrolidine and related derivatives useful as PR modulators |
| 02/21/2008 | US20080045556 4-[2-(4,4-Dimethyl-2-thioxo-1,3-oxazolidin-3-yl)-1,3-thiazol-4-yl]benzonitrile; progesterone receptor (PR); contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, hormone replacement therapy |
| 02/21/2008 | US20080045527 Immunomodulating Heterocyclic Compounds |
| 02/21/2008 | US20080045518 3-[4-(4-Bromophenyl)-1,3-thiazol-2-yl]-4-methyl-1,3-oxazolidin-2-one; alternative progesterone receptor modulator; contraception, fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, hormone replacement therapy, eating disorder, synchronizing estrus |
| 02/21/2008 | US20080044450 Sustained Release Composition |
| 02/21/2008 | US20080044428 Glycosylphosphatidylinositol Glycan Signalling Via Integrins Functioning as Glycan Specific Receptors |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044355 including cystic fibrosis transmembrane conductance regulator ("CFTR"); amido-phenyl derivatives; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema, hereditary hemochromatosis, coagulation-fibrinolysis and lipid processing deficiencies, lysosomal storage disease |
| 02/20/2008 | EP1889914A1 Compositions for gene therapy of diabetes |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1889618A1 Combined drug for treating diabetes |
| 02/20/2008 | EP1888615A1 17 -hsd1 and sts inhibitors |
| 02/20/2008 | EP1888524A1 Androgen modulators |
| 02/20/2008 | EP1572211B1 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 02/20/2008 | EP1408966B1 Synergistic pharmaceutical combinations for the prevention or treatment of diabetes |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | CN101128484A Compositions and methods relating to anti IGF-1 receptor antibodies |
| 02/20/2008 | CN101128476A 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same |
| 02/20/2008 | CN101125132A Oral insulin enteric capsule and its preparation method |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332503 Aporphine esters and their use in therapy |
| 02/19/2008 | US7332493 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/14/2008 | WO2008018872A1 Therapeutic methods of using estrogen compositions |
| 02/14/2008 | WO2008018472A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | US20080039509 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity |
| 02/14/2008 | US20080038387 Therapy of estrogen-associated disorders |
| 02/14/2008 | US20080038292 comprises alkali metal salt, alkaline earth metal salt, and citrate/phosphate buffer; improved stability |
| 02/14/2008 | CA2660330A1 Novel monoclonal antibody and use of the same |
| 02/13/2008 | EP1887000A1 Arylacetate derivative having isoxazole skeleton |
| 02/13/2008 | EP1886999A2 Bicyclic heteroaromatic compound |
| 02/13/2008 | EP1886695A1 Pharmaceutical combination of an aldosterone synthase inhibitor and a glucocorticoid receptor antagonist or a cortisol synthesis inhibitor or a corticotropin releasing factor antagonist |